Francesca Bottazzi

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immune-mediated necrotizing myopathies: clinico-serological features and treatment outcomes of a large Italian cohort of patients.

Immune-mediated necrotizing myopathies: clinico-serological features and treatment outcomes of a large Italian cohort of patients.

Journal: Journal of neurology

Published: May 04, 2026

Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab.

Targeting type I interferon in lupus autoimmune haemolytic anaemia: first report with anifrolumab.

Journal: Lupus science & medicine

Published: March 27, 2026

Reproductive transitions and autoimmunity: implications for women's health in rheumatology and gastroenterology.

Reproductive transitions and autoimmunity: implications for women's health in rheumatology and gastroenterology.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: March 17, 2026

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Journal: The Lancet. Rheumatology

Published: February 17, 2026

Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.

Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.

Journal: The Lancet. Rheumatology

Published: July 26, 2025

Assessment of myositis specific antibodies in primary chronic arthritis: single centre prospective study.

Assessment of myositis specific antibodies in primary chronic arthritis: single centre prospective study.

Journal: Clinical and experimental rheumatology

Published: May 18, 2025

Idiopathic inflammatory myopathies: one year in review 2024.

Idiopathic inflammatory myopathies: one year in review 2024.

Journal: Clinical and experimental rheumatology

Published: February 09, 2025

Efficacy of anifrolumab as a first-line therapy for the treatment of thrombocytopenia in systemic lupus erythematosus: a case report.

Efficacy of anifrolumab as a first-line therapy for the treatment of thrombocytopenia in systemic lupus erythematosus: a case report.

Journal: Clinical and experimental rheumatology

Published: November 25, 2024

Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polyangiitis in a patient treated with dupilumab.

Nivolumab and ipilimumab-induced eosinophilic granulomatosis with polyangiitis in a patient treated with dupilumab.

Journal: Clinical and experimental rheumatology

Published: August 03, 2024

Idiopathic inflammatory myopathies: one year in review 2023.

Idiopathic inflammatory myopathies: one year in review 2023.

Journal: Clinical and experimental rheumatology

Published: January 29, 2024

Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis.

Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis.

Journal: Internal and emergency medicine

Published: April 26, 2023

Idiopathic inflammatory myopathies: one year in review 2022.

Idiopathic inflammatory myopathies: one year in review 2022.

Journal: Clinical and experimental rheumatology

Published: January 04, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026